View in EDS

436TiP COLSTAR: Randomized, open-label, multicentre, phase III study comparing futuximab/modotuximab plus trifluridine/tipiracil to trifluridine/tipiracil in KRAS/NRAS and BRAF wild type (wt) metastatic colorectal cancer (mCRC) previously treated with both standard and anti-EGFR treatment

Saved in:
Bibliographic Details
Title: 436TiP COLSTAR: Randomized, open-label, multicentre, phase III study comparing futuximab/modotuximab plus trifluridine/tipiracil to trifluridine/tipiracil in KRAS/NRAS and BRAF wild type (wt) metastatic colorectal cancer (mCRC) previously treated with both standard and anti-EGFR treatment
Authors: Ciardiello, F.1 (AUTHOR), Yoshino, T.2 (AUTHOR), Modest, D.P.3 (AUTHOR), Martin Fernandez, L.4 (AUTHOR), Roby, L.4 (AUTHOR), Fougeray, R.4 (AUTHOR), Lockhart, B.P.5 (AUTHOR), Tabernero, J.6 (AUTHOR)
Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS733-S734. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 159077369
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 436TiP COLSTAR: Randomized, open-label, multicentre, phase III study comparing futuximab/modotuximab plus trifluridine/tipiracil to trifluridine/tipiracil in KRAS/NRAS and BRAF wild type (wt) metastatic colorectal cancer (mCRC) previously treated with both standard and anti-EGFR treatment
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Ciardiello%2C+F%2E%22">Ciardiello, F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yoshino%2C+T%2E%22">Yoshino, T.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Modest%2C+D%2EP%2E%22">Modest, D.P.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martin+Fernandez%2C+L%2E%22">Martin Fernandez, L.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Roby%2C+L%2E%22">Roby, L.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fougeray%2C+R%2E%22">Fougeray, R.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lockhart%2C+B%2EP%2E%22">Lockhart, B.P.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tabernero%2C+J%2E%22">Tabernero, J.</searchLink><relatesTo>6</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2022 Supplement 7, Vol. 33, pS733-S734. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159077369
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2022.07.574
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S733
    Titles:
      – TitleFull: 436TiP COLSTAR: Randomized, open-label, multicentre, phase III study comparing futuximab/modotuximab plus trifluridine/tipiracil to trifluridine/tipiracil in KRAS/NRAS and BRAF wild type (wt) metastatic colorectal cancer (mCRC) previously treated with both standard and anti-EGFR treatment
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ciardiello, F.
      – PersonEntity:
          Name:
            NameFull: Yoshino, T.
      – PersonEntity:
          Name:
            NameFull: Modest, D.P.
      – PersonEntity:
          Name:
            NameFull: Martin Fernandez, L.
      – PersonEntity:
          Name:
            NameFull: Roby, L.
      – PersonEntity:
          Name:
            NameFull: Fougeray, R.
      – PersonEntity:
          Name:
            NameFull: Lockhart, B.P.
      – PersonEntity:
          Name:
            NameFull: Tabernero, J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2022 Supplement 7
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 33
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1